;

Search Results:

Showing of 50

CLINICAL TRIAL18501

A Randomized,Placebo Controlled Phase 2b/3 Study of ABT 414 with Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects with Newly Diagnosed Glioblastoma (GBM) with Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance 1)

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL18574

A Randomized Phase 3 Open Label Study of Nivolumab vs Temozolomide Each in Combination with Radiation Therapy in Newly Diagnosed Adult Subjects with Unmethylated MGMT (tumor O-6-methylguanine DNA methyltransferase) Glioblastoma

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL17978

A Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) with MK-3475 and Bevacizumab in Patients with Recurrent High Grade Gliomas

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL18647

A Randomized Phase 2 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6-methylguanine DNA methyltransferase) Glioblastoma

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL18093

A Phase 2 Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL18093

A Phase 2 Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL18660

Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas With SMO/AKT/NF2 Mutations

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL19332

An Early Stage Biomarker Study of A Multi-Platform Analysis of a "Liquid Biopsy" of CSF in Patients with Leptomeningeal Disease and Other Brain Tumors To Improve Diagnosis and Treatment

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL19339

A Phase II Trial of AZD9291 (Osimertinib) with or without Bevacizumab in Patients with EGFR Mutation Positive NSCLC and Brain Metastases

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL18576

A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL19385

A Randomized Phase 2 trial of Cediranib and Olaparib Compared to Bevacizumab in Patients with Recurrent Glioblastoma who have not Received Prior VEGF Therapy

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL18308

A Phase II/III Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with MGMT Promoter Hypermethylation

Cancer Type: Neurologic Oncology

View Trial Details